欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Ituxredi	Human	rituximab	rituximab	EMEA/H/C/006224	Reddy Holding GmbH	2024/09/19	Authorised
Ruxience	Human	rituximab	rituximab	EMEA/H/C/004696	Pfizer Europe MA EEIG	2020/04/01	Authorised
Blitzima	Human	rituximab	rituximab	EMEA/H/C/004723	Celltrion Healthcare Hungary Kft.	2017/07/13	Authorised
Ritemvia	Human	rituximab	rituximab	EMEA/H/C/004725	Celltrion Healthcare Hungary Kft.	2017/07/13	Withdrawn
Rituzena (previously Tuxella)	Human	rituximab	rituximab	EMEA/H/C/004724	Celltrion Healthcare Hungary Kft.	2017/07/13	Withdrawn
Rixathon	Human	rituximab	rituximab	EMEA/H/C/003903	Sandoz GmbH	2017/06/15	Authorised
Riximyo	Human	rituximab	rituximab	EMEA/H/C/004729	Sandoz GmbH	2017/06/15	Authorised
Truxima	Human	rituximab	rituximab	EMEA/H/C/004112	Celltrion Healthcare Hungary Kft.	2017/02/17	Authorised
MabThera	Human	rituximab	rituximab	EMEA/H/C/000165	Roche Registration GmbH	1998/06/02	Authorised
Rituximab Mabion	Human	rituximab	rituximab	EMEA/H/C/005387	Mabion Spolka Akcyjna		Application withdrawn

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-